Corleen M. Roche

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Exton, PA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Corleen Roche
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Corleen M. Roche

Form 4 holding CFO

CG Oncology, Inc.

Security class
Employee Stock Option (Right to Buy)
Shares / value
143,907
Estimated value
Report date
15 Apr 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CFO

CG Oncology, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
93,600
Estimated value
Report date
04 Oct 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

Immunome Inc.

Security class
Stock Option (Right to Buy)
Shares / value
58,000
Estimated value
Report date
08 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Corleen M. Roche

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .